XYMOGEN

think we’ve done so, pretty well.” Today, XYMOGEN supplies approximately 12,000 practitioners, offering over 400 products made from 1,200 different ingredients. Its biggest markets are the United States and Canada, but it also has clients in South Korea, South Africa, In- donesia, China, and Iran. Its 430 employees work out of its 240,000-square-foot, Orlando head- quarters, and a distribution outlet in Mississauga, Ontario. Its raw materials, as well as its knowl- edge base, come from all over the world. According to Blackburn, the company’s manu- facturing facility is the newest in the industry, and it’s about to get much bigger. “Our purpose- built manufacturing facility is 136,000 square feet and we are outgrowing that,” he relates. “So, it was very fortuitous that there’s a moving com- pany next door that went out of business, right when we were looking for space. That opened up 120,000 more square feet for us and now we’re close to 260,000 square feet. And that’s enabled us to move forward with many new initiatives.” “One is called Private Label Now,” Blackburn continues. “Private labels are very common in all industries, but I don’t know that any other compa- ny in any industry has anything quite like it. Our customers are practitioners and our minimum or- der is 12 bottles; so they might call up and order 12 of one, 24 of another. In this regulatory envi- ronment, you have to go through several steps to